Viromed Medical AG (FRA:VME)

Germany · Delayed Price · Currency is EUR

4.620

-0.140 (-2.94%)

At close: Oct 23, 2026

Market Cap	99.88M +40.9%
Revenue (ttm)	5.22M +115.7%
Net Income	342.08K
EPS	n/a
Shares Out	n/a
PE Ratio	291.97
Forward PE	32.22
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	4.760
Previous Close	4.760
Day's Range	4.620 - 4.760
52-Week Range	3.000 - 8.300
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 29, 2026

About Viromed Medical AG

Viromed Medical AG engages in the development, manufacture, and distribution of medical products in Germany and internationally. The company offers ViroCAP, an application in dermatology and wound treatment; and PulmoPlas for the treatment of severe respiratory infections. It also provides non-prescription health products in the cosmetics, nutritional supplement, and medical and nursing supplies. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was founded in 2021 and is based in Rellingen, Germany. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2021

Employees 17

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol VME

Financial Performance

Financial Statements